USANA Health Sciences Details CEO Return, Unmet Performance Targets, and Executive Compensation for 2026 Annual Meeting

summarizeSummary

USANA Health Sciences filed its definitive proxy statement for the 2026 Annual Meeting, detailing Kevin Guest's return as CEO, the cancellation of 2023 performance-based equity awards due to unmet conditions, and outlining new performance incentives and executive compensation.

check_boxKey Events

• CEO Reappointed Amidst Leadership Change

  Kevin G. Guest reassumed the Chief Executive Officer role on January 8, 2026, after Jim H. Brown stepped down. Mr. Guest also continues to serve as Chairman of the Board.

• Performance-Based Equity Awards Cancelled Due to Unmet Conditions

  The 2023 Performance Stock Units (PSUs) granted to Named Executive Officers were cancelled in February 2026 because the market and performance conditions for the four-year vesting period were not achieved, signaling past underperformance.

• New Performance-Based Incentive Program Approved

  A new 2026 PSU Award was approved, linking executive payouts to the company's share price outperforming the Russell 2000 Index and achieving positive Total Shareholder Return over a four-year period.

• Executive Compensation Details Disclosed

  The filing provides comprehensive executive compensation data for Fiscal Year 2025, including a CEO pay ratio of 85 to 1, and outlines the 2026 Executive Bonus Plan with targets based on net sales growth and adjusted operating profit.

auto_awesomeAnalysis

This definitive proxy statement reveals significant leadership changes and a clear indication of past underperformance. Kevin Guest's return as CEO, following Jim H. Brown's departure, occurs amidst a challenging financial period for the company, as highlighted by the 74.4% decrease in net earnings reported in the recent 10-K. The cancellation of the 2023 performance-based stock units (PSUs) for executives due to unmet conditions is a strong signal of failure to achieve prior strategic goals and directly impacts executive accountability. While new 2026 PSU awards aim to realign incentives with future stock performance, investors should carefully consider the historical underperformance and the implications of this leadership transition on future strategy. The detailed executive compensation, including an 85:1 CEO pay ratio, will be subject to a "Say on Pay" vote.